- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued based on future growth
Global Pharmaceuticals & Biotech Undervalued based on future growth
Results
50
1 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
50 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
300122 | CN¥27.93 | -0.8% | -54.3% | CN¥66.9b | CN¥36.39 | PE18.1x | E35.4% | 2.9% | ||
HALO | US$48.13 | 2.5% | 30.2% | US$6.1b | US$64.13 | PE15.6x | E21.1% | n/a | ||
000661 | CN¥101.31 | 0.3% | -30.5% | CN¥40.7b | n/a | PE11x | E19.4% | 4.4% | ||
RICHTER | Ft10,480.00 | 0% | 19.8% | Ft1.9t | Ft12,149.33 | PE9x | E14.2% | 4.1% | ||
APN New | R170.00 | -2.2% | -16.5% | R75.5b | R221.50 | PE17.1x | E21.9% | 2.1% | ||
000623 | CN¥17.87 | -0.6% | 18.0% | CN¥21.4b | n/a | PE14.9x | E38.1% | 2.2% | ||
ACAD | US$16.95 | 0.5% | -45.9% | US$2.9b | US$25.11 | PE21.9x | E28.0% | n/a | ||
867 | HK$7.52 | 1.5% | -45.7% | HK$18.2b | HK$10.78 | PE12.3x | E21.4% | 5.5% | ||
1795 | NT$271.50 | 4.2% | -0.2% | NT$72.0b | NT$398.80 | PE16.6x | E22.3% | 1.7% | ||
600867 | CN¥8.20 | -1.6% | -24.3% | CN¥16.0b | CN¥10.45 | PE46.8x | E67.6% | 3.0% | ||
HRMY | US$34.20 | -0.2% | 5.9% | US$2.0b | US$53.88 | PE15.9x | E34.5% | n/a | ||
600129 | CN¥25.93 | -3.0% | -44.2% | CN¥14.4b | CN¥28.00 | PE23.7x | E31.0% | 1.2% | ||
HYPE3 | R$18.03 | -0.1% | -49.6% | R$11.5b | R$30.91 | PE7.3x | E14.0% | 6.8% | ||
1530 | HK$5.93 | -2.0% | -21.1% | HK$14.0b | HK$8.26 | PE7.9x | E16.4% | 4.0% | ||
SQURPHARMA | ৳216.60 | -2.8% | 3.0% | ৳192.0b | ৳319.47 | PE9.1x | E12.9% | 5.1% | ||
605507 | CN¥21.02 | 2.4% | 19.7% | CN¥11.6b | CN¥26.24 | PE16.5x | E22.6% | 1.4% | ||
688276 | CN¥26.09 | -1.0% | -52.4% | CN¥10.8b | CN¥31.99 | PE26.1x | E39.3% | 0.6% | ||
301207 | CN¥18.10 | -1.9% | -34.9% | CN¥10.8b | CN¥25.78 | PE21.6x | E33.3% | 3.3% | ||
002332 | CN¥10.19 | -2.5% | -20.2% | CN¥10.1b | CN¥16.36 | PE16.2x | E22.0% | 2.9% | ||
LAB B | Mex$25.60 | -0.7% | 80.8% | Mex$24.4b | Mex$26.83 | PE15.1x | E19.4% | 3.1% | ||
300406 | CN¥13.97 | -3.4% | -26.9% | CN¥8.2b | CN¥23.15 | PE15.5x | E23.2% | 1.4% | ||
2186 | HK$2.20 | 2.8% | -41.0% | HK$8.3b | HK$3.40 | PE10.1x | E14.4% | 0% | ||
300841 | CN¥58.78 | 1.2% | -24.2% | CN¥7.6b | CN¥75.18 | PE14x | E18.0% | 3.4% | ||
FYB | €52.60 | 2.5% | -6.7% | €928.8m | €87.00 | PE14.5x | E30.6% | n/a |